Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

INTRODUCTION: Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs). MATERIALS AND METHODS: We retrospectively analysed the clinical features, treatment response, and long-term outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiyama-Fujita, Yuriko, Nakazato, Tomonori, Iriyama, Noriyoshi, Tokuhira, Michihide, Ishikawa, Maho, Sato, Eriko, Takaku, Tomoiku, Sugimoto, Keiji, Fujita, Hiroyuki, Fujioka, Isao, Tsuchiya, Shun, Kimura, Yuta, Iwanaga, Eisaku, Komatsu, Norio, Asou, Norio, Kizaki, Masahiro, Hatta, Yoshihiro, Kawaguchi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126594/
https://www.ncbi.nlm.nih.gov/pubmed/35486442
http://dx.doi.org/10.1080/07853890.2022.2069280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126594/
https://www.ncbi.nlm.nih.gov/pubmed/35486442
http://dx.doi.org/10.1080/07853890.2022.2069280

Ejemplares similares